GlassScriptPhysician profile
Joel E Tennenhouse
NPI 1528171436
$900.51
in general payments reported to CMS, 2019-2025
11 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.91 · 2020: $34.16 · 2021: $41.73 · 2022: $317 · 2023: $34.92 · 2024: $271 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $315.93 | 2022-2024 | Ruby Coil |
| Terumo Medical Corporation | $258.66 | 2024-2025 | Azur Cx Detachable, Tr Band, Glidesheath Slender |
| Intuitive Surgical, INC. | $102.56 | 2025 | |
| Boston Scientific Corporation | $84.43 | 2020-2024 | Embold Fibered |
| Becton, Dickinson and Company | $30.91 | 2024 | Provena Midline |
| Argon Medical Devices, INC. | $24.21 | 2019 | |
| Bard Access Systems, INC. | $23.14 | 2021 | |
| Medtronic, INC. | $18.59 | 2021 | |
| Teleflex LLC | $14.44 | 2023 | Arrow |
| Medtronic Vascular, INC. | $13.94 | 2020 | |
| Siemens Medical Solutions USA, INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Tennenhouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.